-
Posted by
Two Blokes Jun 16 -
Filed in
Stock
-
6 views
Centessa Pharmaceuticals (CNTA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.